Staphylococcal Vaccine Antigens related to biofilm formation

References

• Anderson AS, Scully IL, Timofeyeva Y, Murphy E, McNeil LK, Mininni T, Nuñez L, Carriere M, Singer C, Dilts DA, et al. Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis. J Infect Dis. 2012;205(11):1688–96. doi:10.1093/infdis/jis272.
   PubMed Web of Science ®Google Scholar
• van Belkum A. Staphylococcal colonization and infection: homeostasis versus disbalance of human (innate) immunity and bacterial virulence. Curr Opin Infect Dis. 2006;19(4):339–44. doi:10.1097/01.qco.0000235159.40184.61.
   PubMed Web of Science ®Google Scholar
• Jones SM, Morgan M, Humphrey TJ, Lappin-Scott H. Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms. Lancet (London, England). 2001;357(9249):40–41. doi:10.1016/s0140-6736(00)03572-8.
   PubMed Web of Science ®Google Scholar
• Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, et al. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun. 2006;74(4):2215–23. doi:10.1128/iai.74.4.2215-2223.2006.
   PubMed Web of Science ®Google Scholar
• Hogea C, Van Effelterre T, Cassidy A. A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures? BMC Infect Dis. 2014;14(1):291. doi:10.1186/1471-2334-14-291.
   PubMedGoogle Scholar
• Van Mellaert L, Shahrooei M, Hofmans D, Eldere JV. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects. Expert Rev Vaccines. 2012;11(3):319–34. doi:10.1586/erv.11.190.
   PubMed Web of Science ®Google Scholar
• Sellman BR, Howell AP, Kelly-Boyd C, Baker SM. Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect Immun. 2005;73(10):6591–600. doi:10.1128/iai.73.10.6591-6600.2005.
   PubMed Web of Science ®Google Scholar
• Fattom A, Shepherd S, Karakawa W. Capsular polysaccharide serotyping scheme for Staphylococcus epidermidis. J Clin Microbiol. 1992;30:3270–73. doi:10.1128/JCM.30.12.3270-3273.1992.
   PubMed Web of Science ®Google Scholar
• Otto M. Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol. 2006;306:251–58. doi:10.1007/3-540-29916-5_10.
   PubMed Web of Science ®Google Scholar
• Kloos WE, Schleifer KH. Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol. 1975;1:82–88. doi:10.1128/JCM.1.1.82-88.1975.
   PubMed Web of Science ®Google Scholar
• Mirzaei B, Mousavi SF, Babaei R, Bahonar S, Siadat SD, Shafiee Ardestani M, Shahrooei M, Van Eldere J. Synthesis of conjugated PIA–rSesC and immunological evaluation against biofilm-forming Staphylococcus epidermidis. J Med Microbiol. 2019;68(5):791–802. doi:10.1099/jmm.0.000910.
   PubMed Web of Science ®Google Scholar
• Juhlin A, Svensson S, Thomsen P, Trobos M. Staphylococcal biofilm gene expression on biomaterials - A methodological study. Journal of Biomedical Materials Research Part A. 2017;105(12):3400–12. doi:10.1002/jbm.a.36171.
   PubMed Web of Science ®Google Scholar
• Boles BR, Horswill AR. Staphylococcal biofilm disassembly. Trends Microbiol. 2011;19(9):449–55. doi:10.1016/j.tim.2011.06.004.
   PubMed Web of Science ®Google Scholar
• Paharik AE, Horswill AR. The Staphylococcal Biofilm: adhesins, Regulation, and Host Response. Micro Spe. 2016;4(2). doi:10.1128/microbiolspec.VMBF-0022-2015.
   PubMed Web of Science ®Google Scholar
• Kiedrowski MR, Horswill AR. New approaches for treating staphylococcal biofilm infections. Ann N Y Acad Sci. 2011;1241(1):104–21. doi:10.1111/j.1749-6632.2011.06281.x.
   PubMedGoogle Scholar
• Paharik AE, Horswill AR. The staphylococcal biofilm: adhesins, regulation, and host response. Virulence Mechan Bact Path. 2016;22:529–66.
   Google Scholar
• Hu J, Xu T, Zhu T, Lou Q, Wang X, Wu Y, Huang R, Liu J, Liu H, Yu F. Monoclonal antibodies against accumulation-associated protein affect EPS biosynthesis and enhance bacterial accumulation of Staphylococcus epidermidis. PLoS One. 2011;6(6):e20918. doi:10.1371/journal.pone.0020918.
   PubMed Web of Science ®Google Scholar
• Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, et al. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun. 2006;74(4):2215–23. doi:10.1128/IAI.74.4.2215-2223.2006.
   PubMed Web of Science ®Google Scholar
• Zhang Y-Q, Ren S-X, Li H-L, Wang Y-X, Fu G, Yang J, Qin Z-Q, Miao Y-G, Wang W-Y, Chen R-S, et al. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol. 2003;49(6):1577–93. doi:10.1046/j.1365-2958.2003.03671.x.
   PubMed Web of Science ®Google Scholar
• Gill SR, Fouts DE, Archer GL, Mongodin EF, DeBoy RT, Ravel J, Paulsen IT, Kolonay JF, Brinkac L, Beanan M, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol. 2005;187(7):2426–38. doi:10.1128/jb.187.7.2426-2438.2005.
   PubMed Web of Science ®Google Scholar
• Bowden MG, Chen W, Singvall J, Xu Y, Peacock SJ, Valtulina V, Speziale P, Höök M. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology (Reading, England). 2005;151(5):1453–64. doi:10.1099/mic.0.27534-0.
   PubMedGoogle Scholar
• Bambini S, Rappuoli R. The use of genomics in microbial vaccine development. Drug Discov Today. 2009;14(5–6):252–60. doi:10.1016/j.drudis.2008.12.007.
   PubMed Web of Science ®Google Scholar
• Meinke A, Henics T, Hanner M, Minh DB, Nagy E. Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Vaccine. 2005;23(17–18):2035–41. doi:10.1016/j.vaccine.2005.01.005.
   PubMed Web of Science ®Google Scholar
• Pourmand MR, Clarke SR, Schuman RF, Mond JJ, Foster SJ. Identification of antigenic components of Staphylococcus epidermidis expressed during human infection. Infect Immun. 2006;74:4644–54. doi:10.1128/iai.00521-06.
   PubMed Web of Science ®Google Scholar
• De Groot AS. Immunomics: discovering new targets for vaccines and therapeutics. Drug Discov Today. 2006;11(5–6):203–09. doi:10.1016/s1359-6446(05)03720-7.
   PubMed Web of Science ®Google Scholar
• Arora S, Uhlemann A-C, Lowy FD, Hook M. A novel MSCRAMM subfamily in coagulase negative staphylococcal species. Front Microbiol. 2016;7:540. doi:10.3389/fmicb.2016.00540.
   PubMed Web of Science ®Google Scholar
• Heilmann C. In Bacterial adhesion. Springer Dordrecht; 2011. p. 105–23.
   Google Scholar
• Otto M. Bacterial evasion of antimicrobial peptides by biofilm formation. Antimicrobial peptides and human disease: Springer, 2006:251–8.
   Google Scholar
• Otto M. Staphylococcus epidermidis—the’accidental’pathogen. Nat Rev Microbiol. 2009;7(8):555. doi:10.1038/nrmicro2182.
   PubMed Web of Science ®Google Scholar
• Van Mellaert L, Shahrooei M, Hofmans D, Eldere JV. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects. Expert Rev Vaccines. 2012;11(3):319–34. doi:10.1586/erv.11.190.
   PubMed Web of Science ®Google Scholar
• Speziale P, Pietrocola G, Foster TJ, Geoghegan JA. Protein-based biofilm matrices in Staphylococci. Front Cell Infect Microbiol. 2014;4:171. doi:10.3389/fcimb.2014.00171.
   PubMed Web of Science ®Google Scholar
• Herman P, El-Kirat-Chatel S, Beaussart A, Geoghegan JA, Foster TJ, Dufrêne YF. The binding force of the staphylococcal adhesin SdrG is remarkably strong. Mol Microbiol. 2014;93(2):356–68. doi:10.1111/mmi.12663.
   PubMed Web of Science ®Google Scholar
• Vanzieleghem T, Herman-Bausier P, Dufrene YF, Mahillon J. Staphylococcus epidermidis Affinity for Fibrinogen-Coated Surfaces Correlates with the Abundance of the SdrG Adhesin on the Cell Surface. ACS J Surf Colloids. 2015;31(16):4713–21. doi:10.1021/acs.langmuir.5b00360.
   Google Scholar
• Ganesh VK, Rivera JJ, Smeds E, Ko Y-P, Bowden MG, Wann ER, Gurusiddappa S, Fitzgerald JR, Höök M. A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. PLoS Pathog. 2008;4:e1000226. doi:10.1371/journal.ppat.1000226.
   PubMed Web of Science ®Google Scholar
• Bowden MG, Heuck AP, Ponnuraj K, Kolosova E, Choe D, Gurusiddappa S, Narayana SVL, Johnson AE, Höök M. Evidence for the “dock, lock, and latch” ligand binding mechanism of the staphylococcal microbial surface component recognizing adhesive matrix molecules (MSCRAMM) SdrG. J Biol Chem. 2008;283(1):638–47. doi:10.1074/jbc.M706252200.
   PubMed Web of Science ®Google Scholar
• Claro T, Kavanagh N, Foster TJ, O’Brien FJ, Kerrigan SW. Staphylococcus epidermidis serine–aspartate repeat protein G (SdrG) binds to osteoblast integrin alpha V beta 3. Microbes and Infection. 2015;17(6):395–401. doi:10.1016/j.micinf.2015.02.003.
   PubMed Web of Science ®Google Scholar
• Arciola CR, Campoccia D, Gamberini S, Donati ME, Montanaro L. Presence of fibrinogen-binding adhesin gene in Staphylococcus epidermidis isolates from central venous catheters-associated and orthopaedic implant-associated infections. Biomaterials. 2004;25(19):4825–29. doi:10.1016/j.biomaterials.2003.11.056.
   PubMed Web of Science ®Google Scholar
• McCrea KW, Hartford O, Davis S, Eidhin DN, Lina G, Speziale P, Foster TJ, Höök M. The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis The GenBank accession numbers for the sequences determined in this work are AF245041 (sdrF), AF245042 (sdrG) and AF245043 (sdrH). Microbiology (Reading, England). 2000;146(7):1535–46. doi:10.1099/00221287-146-7-1535.
   PubMedGoogle Scholar
• Nilsson M, Frykberg L, Flock J-I, Pei L, Lindberg M, Guss B. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun. 1998;66(6):2666–73. doi:10.1128/IAI.66.6.2666-2673.1998.
   PubMed Web of Science ®Google Scholar
• Sellman BR, Timofeyeva Y, Nanra J, Scott A, Fulginiti JP, Matsuka YV, Baker SM. Expression of Staphylococcus epidermidis SdrG increases following exposure to an in vivo environment. Infect Immun. 2008;76(7):2950–57. doi:10.1128/iai.00055-08.
   PubMed Web of Science ®Google Scholar
• Vernachio JH, Bayer AS, Ames B, Bryant D, Prater BD, Syribeys PJ, Gorovits EL, Patti JM. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo. Antimicrob Agents Chemother. 2006;50(2):511–18. doi:10.1128/aac.50.2.511-518.2006.
   PubMed Web of Science ®Google Scholar
• Bloom BT. INH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection. Expert Opin Investig Drugs. 2006;15(6):703–07. doi:10.1517/13543784.15.6.703.
   PubMed Web of Science ®Google Scholar
• Arrecubieta C, Lee MH, Macey A, Foster TJ, Lowy FD, SdrF A. Staphylococcus epidermidis Surface Protein, Binds Type I Collagen. J Biol Chem. 2007;282(26):18767–76. doi:10.1074/jbc.M610940200.
   PubMed Web of Science ®Google Scholar
• Arrecubieta C, Toba FA, von Bayern M, Akashi H, Deng MC, Naka Y, Lowy FD. SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections. PLoS Pathog. 2009;5:e1000411. doi:10.1371/journal.ppat.1000411.
   PubMed Web of Science ®Google Scholar
• Bowden MG, Visai L, Longshaw CM, Holland KT, Speziale P, Höök M. Is the GehD Lipase from Staphylococcus epidermidis a Collagen Binding Adhesin? J Biolog Chem. 2002;277(45):43017–23. doi:10.1074/jbc.M207921200.
   PubMed Web of Science ®Google Scholar
• Longshaw CM, Farrell AM, Wright JD, Holland KT. Identification of a second lipase gene, gehD, in Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal lipases. Microbiology (Reading, England). 2000;146(Pt 6):1419–27. doi:10.1099/00221287-146-6-1419.
   PubMedGoogle Scholar
• Otto M. Staphylococcus epidermidis–the ‘accidental’ pathogen. Nat Rev Microbiol. 2009;7(8):555–67. doi:10.1038/nrmicro2182.
   PubMed Web of Science ®Google Scholar
• de la Morena MT. Specific immune globulin therapy for prevention of nosocomial staphylococcal bloodstream infection in premature infants: not what we hoped for! J Pediatr. 2007;151(3):232–34. doi:10.1016/j.jpeds.2007.06.031.
   PubMed Web of Science ®Google Scholar
• Christner M, Franke GC, Schommer NN, Wendt U, Wegert K, Pehle P, Kroll G, Schulze C, Buck F, Mack D. The giant extracellular matrix-binding protein of Staphylococcus epidermidis mediates biofilm accumulation and attachment to fibronectin. Mol Microbiol. 2010;75(1):187–207. doi:10.1111/j.1365-2958.2009.06981.x.
   PubMed Web of Science ®Google Scholar
• Schommer NN. Staphylococcus epidermidis uses distinct mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like cells 774A.1. Infect Immun. 2011;79:2267–76. doi:10.1128/iai.01142-10.
   PubMed Web of Science ®Google Scholar
• Rennermalm A, Nilsson M, Flock JI. The fibrinogen binding protein of Staphylococcus epidermidis is a target for opsonic antibodies. Infect Immun. 2004;72(5):3081–83. doi:10.1128/IAI.72.5.3081-3083.2004.
   PubMed Web of Science ®Google Scholar
• Hirschhausen N. A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor. Cell Microbiol. 2010;12(12):1746–64. doi:10.1111/j.1462-5822.2010.01506.x.
   PubMed Web of Science ®Google Scholar
• Heilmann C, Thumm G, Chhatwal GS, Hartleib J, Uekötter A, Peters G. Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology (Reading, England). 2003;149(10):2769–78. doi:10.1099/mic.0.26527-0.
   PubMedGoogle Scholar
• Rohde H. Detection of virulence-associated genes not useful for discriminating between invasive and commensal Staphylococcus epidermidis strains from a bone marrow transplant unit. J Clin Microbiol. 2004;42:5614–19. doi:10.1128/jcm.42.12.5614-5619.2004.
   PubMed Web of Science ®Google Scholar
• Frebourg NB, Lefebvre S, Baert S, Lemeland JF. PCR-Based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. J Clin Microbiol. 2000;38(2):877–80. doi:10.1128/JCM.38.2.877-880.2000.
   PubMed Web of Science ®Google Scholar
• Xue T, Ni J, Shang F, Chen X, Zhang M. Autoinducer-2 increases biofilm formation via an ica- and bhp-dependent manner in Staphylococcus epidermidis RP62A. Microbes and Infection. 2015;17(5):345–52. doi:10.1016/j.micinf.2015.01.003.
   PubMed Web of Science ®Google Scholar
• Lasa I, Penades JR. Bap: a family of surface proteins involved in biofilm formation. Res Microbiol. 2006;157(2):99–107. doi:10.1016/j.resmic.2005.11.003.
   PubMed Web of Science ®Google Scholar
• Hennig S, Nyunt Wai S, Ziebuhr W. Spontaneous switch to PIA-independent biofilm formation in an ica-positive Staphylococcus epidermidis isolate. IJMM. 2007;297(2):117–22. doi:10.1016/j.ijmm.2006.12.001.
   Google Scholar
• Shahrooei M, Hira V, Stijlemans B, Merckx R, Hermans PWM, Van Eldere J. Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein. Infect Immun. 2009;77(9):3670–78. doi:10.1128/iai.01464-08.
   PubMed Web of Science ®Google Scholar
• Yao Y, Sturdevant DE, Villaruz A, Xu L, Gao Q, Otto M. Factors characterizing Staphylococcus epidermidis invasiveness determined by comparative genomics. Infect Immun. 2005;73(3):1856–60. doi:10.1128/iai.73.3.1856-1860.2005.
   PubMed Web of Science ®Google Scholar
• Soderquist B, Andersson M, Nilsson M, Nilsdotter-Augustinsson Å, Persson L, Friberg Ö, Jacobsson S. Staphylococcus epidermidis surface protein I (SesI): a marker of the invasive capacity of S. epidermidis? J Med Microbiol. 2009;58(10):1395–97. doi:10.1099/jmm.0.008771-0.
   PubMed Web of Science ®Google Scholar
• Macintosh RL, Brittan JL, Bhattacharya R, Jenkinson HF, Derrick J, Upton M, Handley PS. The terminal A domain of the fibrillar accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes. J Bacteriol. 2009;191(22):7007–16. doi:10.1128/jb.00764-09.
   PubMed Web of Science ®Google Scholar
• Pourmand MR, Abdossamadi Z, Salari MH, Hosseini M. Slime layer formation and the prevalence of mecA and aap genes in Staphylococcus epidermidis isolates. J Infect Dev Ctries. 2011;5:34–40. doi:10.3855/jidc.984.
   PubMed Web of Science ®Google Scholar
• Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies AP, Harris LG, Horstkotte MA. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 2007;28(9):1711–20. doi:10.1016/j.biomaterials.2006.11.046.
   PubMed Web of Science ®Google Scholar
• Sun D, Accavitti MA, Bryers JD. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clinical Diagnostic Laboratory Immunology. 2005;12(1):93–100. doi:10.1128/cdli.12.1.93-100.2005.
   PubMedGoogle Scholar
• Broekhuizen CA, de Boer L, Schipper K, Jones CD, Quadir S, Feldman RG, Vandenbroucke-Grauls CMJE, Zaat SAJ. The influence of antibodies on Staphylococcus epidermidis adherence to polyvinylpyrrolidone-coated silicone elastomer in experimental biomaterial-associated infection in mice. Biomaterials. 2009;30(32):6444–50. doi:10.1016/j.biomaterials.2009.08.018.
   PubMed Web of Science ®Google Scholar
• HAN H, PAK SI, GUIDRY A. Prevalence of capsular polysaccharide (CP) types of Staphylococcus aureus isolated from bovine mastitic milk and protection of S. aureus infection in mice with CP vaccine. Journal of Veterinary Medical Science. 2000;62(12):1331–33. doi:10.1292/jvms.62.1331.
   PubMed Web of Science ®Google Scholar
• Holland LM, Conlon B, O’Gara JP. Mutation of tagO reveals an essential role for wall teichoic acids in Staphylococcus epidermidis biofilm development. Microbiology. 2011;157(2):408–18. doi:10.1099/mic.0.042234-0.
   PubMedGoogle Scholar
• Gruszka DT, Wojdyla JA, Bingham RJ, Turkenburg JP, Manfield IW, Steward A, Leech AP, JA Geoghegon, TJ Foster, J Clarke, JR Potts. Staphylococcal biofilm-forming protein has a contiguous rod-like structure. Proceedings of the National Academy of Sciences 109, E1011–E1018 (2012).
   Google Scholar
• Maira-Litran T, Kropec A, Goldmann DA, Pier GB. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2005;73(10):6752–62. doi:10.1128/iai.73.10.6752-6762.2005.
   PubMed Web of Science ®Google Scholar
• Dotto C, Lombarte Serrat A, Cattelan N, Barbagelata MS, Yantorno OM, Sordelli DO, Ehling-Schulz M, Grunert T, Buzzola FR. The Active Component of Aspirin, Salicylic Acid, Promotes Staphylococcus aureus Biofilm Formation in a PIA-dependent Manner. Front Microbiol. 2017;8(4). doi:10.3389/fmicb.2017.00004.
   PubMedGoogle Scholar
• Ziebuhr W. Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. Int J Antimicrob Agents. 2006;28(1):S14–20. doi:10.1016/j.ijantimicag.2006.05.012.
   PubMedGoogle Scholar
• Mack D, Davies AP, Harris LG, Knobloch JK, Rohde H. Staphylococcus epidermidis Biofilms: functional Molecules, Relation to Virulence, and Vaccine Potential. Top Curr Chem. 2009;288:157–82. doi:10.1007/128_2008_19.
   PubMed Web of Science ®Google Scholar
• Rohde H, Frankenberger S, Zahringer U, Mack D. Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur J Cell Biol. 2010;89(1):103–11. doi:10.1016/j.ejcb.2009.10.005.
   PubMed Web of Science ®Google Scholar
• Rogers KL, Rupp ME, Fey PD. The presence of icaADBC is detrimental to the colonization of human skin by Staphylococcus epidermidis. Appl Environ Microbiol. 2008;74(19):6155–57. doi:10.1128/aem.01017-08.
   PubMed Web of Science ®Google Scholar
• Holland LM, Conlon B, O’Gara JP. Mutation of tagO reveals an essential role for wall teichoic acids in Staphylococcus epidermidis biofilm development. Microbiology (Reading, England). 2011;157(2):408–18. doi:10.1099/mic.0.042234-0.
   PubMedGoogle Scholar
• Weisman LE, Fischer GW, Thackray HM, Johnson KE, Schuman RF, Mandy GT, Stratton BE, Adams KM, Kramer WG, Mond JJ. Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults. Int Immunopharmacol. 2009;9(5):639–44. doi:10.1016/j.intimp.2009.02.008.
   PubMed Web of Science ®Google Scholar
• Weisman LE, Thackray HM, Garcia-Prats JA, Nesin M, Schneider JH, Fretz J, Kokai-Kun JF, Mond JJ, Kramer WG, Fischer GW. A Phase 1/2 double blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study in very low birth weight neonates of pagibaximab (BSYX-A110), an anti-staphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections. Antimicrob Agents Chemother. 2009;1;53(7):2879–86.
   Google Scholar
• Weisman LE, Thackray HM, Steinhorn RH, Walsh WF, Lassiter HA, Dhanireddy R, Brozanski BS, Palmer KGH, Trautman MS, Escobedo M. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics. 2011;128(2):271–79. doi:10.1542/peds.2010-3081.
   PubMed Web of Science ®Google Scholar
• Maira-Litrán T. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A. PLoS One. 2012;7:e43813. doi:10.1371/journal.pone.0043813.
   PubMed Web of Science ®Google Scholar
• Sun D, Accavitti M, Bryers J. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clinical Diagnostic Laboratory Immunology. 2005;12(1):93–100. doi:10.1128/CDLI.12.1.93-100.2005.
   PubMedGoogle Scholar
• Shahrooei M, Hira V, Khodaparast L, Khodaparast L, Stijlemans B, Kucharíková S, Burghout P, Hermans PWM, Van Eldere J. Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation. Infect Immun. 2012;80(10):3660–68. doi:10.1128/IAI.00104-12.
   PubMed Web of Science ®Google Scholar
• Lam H, Kesselly A, Stegalkina S, Kleanthous H, Yethon JA. Antibodies to PhnD inhibit staphylococcal biofilms. Infect Immun. 2014;82:3764–74. doi:10.1128/IAI.02168-14.
   PubMed Web of Science ®Google Scholar
• Patel M, Kaufman DA. Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants. Expert Opin Biol Ther. 2015;15:595–600. doi:10.1517/14712598.2015.1019857.
   PubMed Web of Science ®Google Scholar
• Hofmans D, Khodaparast L, Khodaparast L, Vanstreels E, Shahrooei M, Van Eldere J, Van Mellaert L. Ses proteins as possible targets for vaccine development against Staphylococcus epidermidis infections. J Inf. 2018;77(2):119–30. doi:10.1016/j.jinf.2018.03.013.
   PubMed Web of Science ®Google Scholar